Study of Safety and Efficacy of an Oral Contraceptive

PHASE3CompletedINTERVENTIONAL
Enrollment

938

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Prevention of Pregnancy
Interventions
DRUG

Norethindrone Acetate/Ethinyl Estradiol 24 Days

One tablet per day for 24 days of each 28 day cycle followed by 4 placebo tablets

DRUG

Norethindrone Acetate /Ethinyl Estradiol 21 Days

One tablet per day for 21 days of each 28 day cycle followed by 7 placebo tablets

Trial Locations (34)

15206

Warner Chilcott Investigational Site, Pittsburgh

18104

Warner Chilcott Investigational Site, Allentown

19114

Warner Chilcott Investigational Site, Philadelphia

23233

Warner Chilcott Investigational Site, Richmond

23456

Warner Chilcott Investigational Site, Virginia Beach

23507

Warner Chilcott Investigational Site, Norfolk

27103

Warner Chilcott Investigational Site, Winston-Salem

28562

Warner Chilcott Investigational Site, New Bern

29425

Warner Chilcott Investigational Site, Charleston

29605

Warner Chilcott Investigational Site, Greenville

30033

Warner Chilcott Investigational Site, Decatur

30034

Warner Chilcott Investigational Site, Decatur

30075

Warner Chilcott Investigational Site, Roswell

30127

Warner Chilcott Investigational Site, Powder Springs

31405

Warner Chilcott Investigational Site, Savannah

32207

Warner Chilcott Investigational Site, Jacksonville

33186

Warner Chilcott Investigational Site, Miami

33409

Warner Chilcott Investigational Site, West Palm Beach

33437

Warner Chilcott Investigational Site, Boynton Beach

34285

Warner Chilcott Investigational Site, Venice

34684

Warner Chilcott Investigational Site, Palm Harbor

35233

Warner Chilcott Investigational Site, Birmingham

40202

Warner Chilcott Investigational Site, Louisville

63117

Warner Chilcott Investigational Site, St Louis

64112

Warner Chilcott Investigational Site, Kansas City

80202

Warner Chilcott Investigational Site, Denver

84070

Warner Chilcott Investigational Site, Sandy City

85014

Warner Chilcott Investigational Site, Phoenix

85031

Warner Chilcott Investigational Site, Phoenix

90033

Warner Chilcott Investigational Site, Los Angeles

92103

Warner Chilcott Investigational Site, San Diego

92108

Warner Chilcott Investigational Site, San Diego

95929

Warner Chilcott Investigational Site, Chico

98105

Warner Chilcott Investigational Site, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00932321 - Study of Safety and Efficacy of an Oral Contraceptive | Biotech Hunter | Biotech Hunter